Gregory Stea

No más puestos en curso

66 años

Health Technology

Consumer Services

Perfil

Gregory Stea served as Vice President-Sales at Amgen, Inc. from 1988 to 1997.
He then worked as Principal at Glaxo Pharmaceuticals, Inc. from 1982 to 1988.
Later, he served as Senior Vice President-Commercial Operations at Cubist Pharmaceuticals LLC from 2002 to 2015.
From 2015 to 2019, he worked as Independent Director at Achaogen, Inc. Mr. Stea completed his undergraduate degree from Temple University (Pennsylvania).

Antiguos cargos conocidos de Gregory Stea.

Empresas	Cargo	Fin
ACHAOGEN	Director/Miembro de la Junta	23/07/2019
CUBIST PHARMACEUTICALS INC	Corporate Officer/Principal	01/02/2015
AMGEN INC.	Ventas & Marketing	01/01/1997
Glaxo Pharmaceuticals, Inc.	Corporate Officer/Principal	-

Ver el detalle de la experiencia de Gregory Stea.

Formación de Gregory Stea.

Temple University (Pennsylvania)

Undergraduate Degree

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Gregory Stea.

Relaciones

100 +

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
AMGEN INC.	Health Technology

Empresas privadas	3
Cubist Pharmaceuticals LLC Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Cubist Pharmaceuticals LLC operates as a biopharmaceutical company. It focuses on the research, development and commercialization of pharmaceutical products. The company was founded in 1992 and is headquartered in Lexington, MA.	Health Technology
Glaxo Pharmaceuticals, Inc.
Achaogen, Inc. Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Achaogen, Inc. engages in developing and commercializing innovative antibacterial agents for multi-drug resistant gram-negative infections. The firm is also involved in the development of C-Scape, an orally administered antibiotic to address a serious unmet need for an effective oral treatment for patients with complicated urinary tract infections, including pyelonephritis caused by extended spectrum beta-lactamases producing Enterobacteriaceae. The company was founded by Nathaniel Eames David, Floyd E. Romesberg, and Peter G. Schultz in June 2002 and is headquartered in South San Francisco, CA.	Health Technology

Ver las conexiones de la empresa